CD44 transcript expression in whole liver was explored in the mouse RNA-Seq dataset Fig. 7 (F7), alongside the classical macrophage marker CD68 and two recently identified markers, CD9 and Trem2, associated with NAFLD progression27–29. This evidence concerns the gene TREM2 and metabolic dysfunction-associated steatotic liver disease.